Shrimanker, R., Pavord, I., Price, R., Bradford, E., Keene, O., & Yancey, S. (2018). Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma. American Thoracic Society.
Chicagoスタイル(17版)引用形式Shrimanker, R., I. Pavord, R. Price, E. Bradford, O. Keene, , S. Yancey. Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma. American Thoracic Society, 2018.
MLA(9版)引用形式Shrimanker, R., et al. Fractional Exhaled Nitric Oxide and the Peripheral Blood Eosinophil Count as Biomarkers of the Response to Mepolizumab in Patients with Severe Eosinophilic Asthma. American Thoracic Society, 2018.